Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which were referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
|Active Ingredient:||Ibuprofen 200mg|
|Dosage Form:||Film coated tablet|
|New Zealand Sponsor:||REX Medical Limited|
|Manufacturers:||Cipla Limited, Maharashtra, India
Sharon Bio-Medicine Limited, Dehradun, India
Dated this 21st day of April 2023.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).